Intercept Pharmaceuticals


Intercept Pharmaceuticals Inc (ICPT) Presents Additional Results From Phase 2 Study of OCA for the Treatment of Patients with PSC

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) announced additional results of the phase 2 clinical trial with obeticholic acid (OCA), a potent farnesoid X receptor agonist …

Top Analyst Bullish on Intercept Pharmaceuticals (ICPT) and Cempra Inc (CEMP) in Anticipation of Drug Approvals

Analyst Alan Carr of Needham weighed in on Intercept Pharmaceuticals (NASDAQ:ICPT) and Cempra Inc (NASDAQ:CEMP) today. Intercept Pharmaceuticals Carr maintains a Buy rating on …

Intercept Pharmaceuticals $732 Million Cash Covers Potential PBC Launch and Clinical Progress: Wedbush

Wedbush analyst Liana Moussatos weighed in with her views on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company released its second-quarter results, posting $0.445 million in licensing revenue, compared to consensus …

Intercept Pharmaceuticals Inc (ICPT) Stock Falls Hard On Insider Sale

Intercept Pharmaceuticals Inc (NASDAQ:ICPT) Today was supposed to be a great day for Intercept Pharmaceuticals stock as the company announced forward movement in …

Wedbush Maintains Outperform on Intercept Pharmaceuticals Inc on Back of NASH Competition Results

Wedbush’s healthcare analyst Liana Moussatos weighed in with her views on Intercept Pharmaceuticals Inc (NASDAQ:ICPT), after the company’s two competitors announced phase 2 results …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts